Home » Computer & Software » Internet » Taglich Brothers Initiates Coverage on Trxade Group, Inc.
Ihren XING-Kontakten zeigen

Taglich Brothers Initiates Coverage on Trxade Group, Inc.

NEW YORK, NY — (Marketwired) — 11/25/14 — . announces it initiated coverage of . (OTCQB: TRXD).

. (OTCQB: TRXD), based in Lutz, Florida, operates an Internet-based exchange that promotes and enables trading among independent pharmacies and pharmaceutical suppliers (wholesalers). Currently, the company–s market platform is used mainly by around 2,300 retail pharmacies to purchase drugs from 24 wholesalers (supplier to pharmacy). Proprietary software enables users of Trxade–s network to compare prices of branded and generic drugs, and order products at the most favorable prices prevailing at the time of the search. As wholesale price disparities among vendors are most pronounced in generic drugs, the retail pharmacies– searches tend to focus on this segment of the market.

TRXD has developed a pharmacy acquisition cost (PAC) benchmark against which retail pharmacies can compare quoted supplier prices with the average cost charged retail pharmacies. The PAC benchmark is based on data which includes data obtained in surveys of retail pharmacies and drug wholesalers, statistics on prescription dispensing, and the costs of disposing of old drug inventory.

The Internet-based exchange, currently used mainly by retail pharmacies, also supports transactions between retail pharmacies (pharmacy to pharmacy) seeking to sell excess inventory or drugs that are nearing the expiration of their shelf lives. The exchange can also be used by wholesalers (supplier to supplier) trading with one another. But at this time, the exchange is used solely in supplier to pharmacy transactions.

The company also operates a wholesale business that searches out pharmaceuticals, over-the-counter drugs, and medical supplies that data from the Food and Drug Administration (FDA) or the University of Utah indicate are, or expected to be, in short supply nationwide. The company buys those drugs in anticipation of shortages and resells them at premium prices. The inventory purchased by the TRXD–s wholesale business is maintained and shipped by a third party fulfillment organization.

The complete 17-page report is available at .

We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is fully disclosed with its clearing firm, Pershing, LLC, is not a market maker and does not sell to or buy from customers on a principal basis. The above statement is the opinion of Taglich Brothers, Inc. and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. There may be instances when fundamental, technical and quantitative opinions contained in this report are not in concert. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. Analysts and members of the Research Department are prohibited from buying or selling securities issued by the companies that Taglich Brothers, Inc. has a research relationship with, except if ownership of such securities was prior to the start of such relationship, then an Analyst or member of the Research Department may sell such securities after obtaining expressed written permission from Compliance. As of the date of this report no Taglich Brothers, Inc. employees had a position in the stock of the company mentioned in this report.

All research issued by Taglich Brothers, Inc. is based on public information. All research issued by Taglich Brothers, Inc. is based on public information. In Octobler 2014 the company paid an initial monetary engagement fee of US$6,000 to Taglich Brothers, Inc. representing payment for the first three months of the creation and dissemination of research reports, after which the company will pay Taglich Brothers, Inc. a monetary fee of US$2,000 per month for another three months of such services.

For further information and Taglich Brothers, Inc. ownership data please refer to each individual report.

Contact:
Richard Oh
Taglich Brothers, Inc.
631-757-1500

You must be logged in to post a comment Login


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de Bloggeramt.de blogoscoop